Laboratory Applications of Ibutamoren MK-677
Ibutamoren (MK-677) is a non-peptide growth hormone secretagogue developed for in-vitro research into ghrelin receptor agonism and growth hormone release pathways. This orally bioavailable compound from Biogenic Pharma enables researchers at Stroid UK Shop to investigate pulsatile GH stimulation mechanisms without affecting cortisol levels in preclinical models. The compound demonstrates selective ghrelin receptor binding, making it valuable for studies examining hypothalamic-pituitary axis modulation and metabolic signalling cascades.
Research Applications in Growth Hormone Studies
Researchers utilise Ibutamoren to examine growth hormone secretagogue receptor (GHSR) activation and downstream signalling pathways. The compound has progressed through Phase II clinical studies for GH deficiency and sarcopenia research, providing validated protocols for laboratory investigations. Studies focus on its ability to stimulate pulsatile growth hormone release while maintaining physiological patterns, unlike synthetic peptide alternatives. Research teams investigating Ibutamoren compounds frequently examine its effects on IGF-1 elevation and metabolic parameters in controlled experimental environments. The compound’s oral bioavailability profile makes it particularly suitable for chronic administration studies and long-term research protocols examining growth hormone axis function.
Product Specifications
| Chemical Name | Ibutamoren (MK-677) |
|---|---|
| CAS Number | 159634-47-6 |
| Molecular Formula | C₂₇H₃₆N₄O₅S |
| Molecular Weight | 528.66 g/mol |
| Classification | Growth hormone secretagogue |
| Storage Conditions | Room temperature, dry environment |
| Manufacturer | Biogenic Pharma |
Researchers studying growth hormone secretagogues alongside other compounds often examine SARMs research chemicals and peptide compounds for comprehensive endocrine system investigations. The compound’s mechanism involves ghrelin receptor agonism, distinguishing it from peptide-based growth hormone releasing hormones and providing unique research opportunities for examining non-peptide approaches to GH stimulation.
Research Compliance and Laboratory Use
This Ibutamoren MK-677 product is manufactured by Biogenic Pharma exclusively for in-vitro laboratory research purposes. Researchers must ensure proper laboratory protocols and safety measures when handling this research chemical. The compound is not intended for human consumption, therapeutic use, or any application outside controlled laboratory environments. All research activities must comply with institutional guidelines and applicable regulations governing research chemical use.
